IrisVision is a breakthrough wearable headset that allows the vision impaired and macular degeneration, to see clearly and live fully.
IrisVision has raised $11.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2022.
IrisVision's investors include HealthTech Capital, Mentors Fund, Social Starts.
IrisVision is headquartered in Pleasanton, United States.
IrisVision is a breakthrough wearable headset that allows the vision impaired and macular degeneration, to see clearly and live fully.
IrisVision is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IrisVision — Funding & Investors." VCBacked, March 20, 2022, https://www.vcbacked.co/company/irisvision. Accessed August 14, 2026.
VCBacked. (2022). IrisVision — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/irisvision
{{cite web |title=IrisVision — Funding & Investors |url=https://www.vcbacked.co/company/irisvision |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated